Who Paid My Doc
Vantage Galan 3T
Device Mrt-3020
PDI 04987670102615
General payments
$189,704
Research payments
$0
Through program year 2025, $189,704 in general payments and $0 in research payments were reported against Vantage Galan 3T (Mrt-3020).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $11,200 | 18 |
| 2024 | General | $75,803 | 37 |
| 2023 | General | $19,558 | 32 |
| 2022 | General | $23,252 | 10 |
| 2021 | General | $59,892 | 25 |
Breakdown
The top 5 of 9 recipients; each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
122 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.